Trust Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,802
Closed -$241K 107
2022
Q4
$241K Buy
+2,802
New +$222K 0.23% 79
2022
Q1
Sell
-12,243
Closed -$889K 91
2021
Q4
$889K Buy
12,243
+153
+1% +$10.5K 0.7% 58
2021
Q3
$844K Buy
12,090
+134
+1% +$9.41K 0.75% 61
2021
Q2
$823K Buy
11,956
+472
+4% +$31.5K 0.73% 60
2021
Q1
$742K Buy
+11,484
New +$741K 0.73% 59
2018
Q1
Sell
-4,180
Closed -$299K 86
2017
Q4
$299K Sell
4,180
-1,200
-22% -$91.1K 0.33% 79
2017
Q3
$436K Sell
5,380
-640
-11% -$48.9K 0.49% 74
2017
Q2
$426K Sell
6,020
-400
-6% -$26.6K 0.46% 77
2017
Q1
$436K Buy
6,420
+600
+10% +$42.2K 0.47% 78
2016
Q4
$417K Sell
5,820
-820
-12% -$60.9K 0.47% 72
2016
Q3
$525K Buy
6,640
+215
+3% +$17.5K 0.6% 71
2016
Q2
$536K Sell
6,425
-340
-5% -$30.2K 0.63% 68
2016
Q1
$621K Buy
6,765
+470
+7% +$42.4K 0.7% 63
2015
Q4
$637K Buy
6,295
+575
+10% +$59.8K 0.77% 59
2015
Q3
$562K Hold
5,720
0.64% 61
2015
Q2
$670K Sell
5,720
-1,110
-16% -$121K 0.68% 58
2015
Q1
$670K Sell
6,830
-970
-12% -$98.5K 0.67% 63
2014
Q4
$735K Sell
7,800
-410
-5% -$42.4K 0.75% 55
2014
Q3
$874K Sell
8,210
-290
-3% -$28.4K 0.84% 55
2014
Q2
$705K Sell
8,500
-100
-1% -$7.78K 0.68% 60
2014
Q1
$609K Sell
8,600
-1,000
-10% -$78.4K 0.61% 62
2013
Q4
$721K Buy
+9,600
New +$668K 0.74% 58

Other funds holding GILD

Trust Investment Advisors's GILD Position: Q1 2023 in Review

Trust Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,802 shares — an estimated $241K sold.

Trust Investment Advisors first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $889K in Q4 2021. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Trust Investment Advisors reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Trust Investment Advisors sold 2,802 Gilead Sciences shares in Q1 2023, an estimated $241K.
  • Trust Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
  • Trust Investment Advisors's Gilead Sciences position peaked at $889K in Q4 2021.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Trust Investment Advisors's 13F filing for Q1 2023, filed 12 May 2023.